Background/Aim: Infantile colic (IC) is considered to represent the upper end of the spectrum of early developmental crying behavior. Little is known about hypothalamic-pituitary-adrenocortical axis activity and sleep in relation to infants’ crying. The aim of the present study was to assess cortisol secretion in infants in relation to their sleep and crying patterns. Method: Sixteen infants (mean age: 8 weeks; SD = 1.5 weeks) were enrolled. Their mothers completed a series of questionnaires regarding the infants’ crying and sleeping patterns. The infants’ sleep was objectively assessed with actigraphs. After 4 weeks, the infants were assessed once again. Cortisol secretion was measured by means of saliva samples in the mornings after awakening. Results: Morning saliva cortisol levels were related to more frequent awakening and to increased crying intensity, but not to sleep or crying duration. Over 4 weeks, both crying behavior and sleep duration decreased, but there was no association between them. Cortisol secretion did not significantly change. Conclusions: In infants suffering from IC, fragmented sleep patterns and increased saliva cortisol levels were related. Cortisol secretion seems to be related to crying intensity, but not to crying duration. Crying intensity may reflect greater physiological or psychological stress rather than mere duration of crying.

Keywords:
Sleep, Actigraphy, Hypothalamic-pituitary-adrenocortical axis, Salivary cortisol, Crying behavior, Infantile colic
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.